Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesOnychomycosis and diabetes
Journal of the European Academy of Dermatology and Venereology, 09/17/09
Cathcart S et al. – Terbinafine is an excellent choice in diabetics due to its low risk of drug–drug interaction and proven efficacy against the typical pathogens that cause onychomycosis. Itraconazole, while an effective treatment for onychomycosis, is not a first–choice therapy due to its black–box cardiac warning and numerous drug interactions. Larger studies are needed in diabetics to determine the frequency of candidal nail infections.
Related Articles
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
Clinical and Experimental Dermatology, 11/02/09
Relevance Score: 87%
Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
British Journal of Dermatology, 10/07/09
Relevance Score: 87%
Onychomycosis caused by Phaeoacremonium parasiticum: first case report
Mycoses, 10/01/09
Relevance Score: 85%
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Detection and Species Identification of Leishmania DNA from Filter Paper Lesion Impressions for Patients with American Cutaneous Leishmaniasis
Clinical Infectious Diseases, 12/11/09
A novel human skin chamber model to study wound infection ex vivo
Archives of Dermatological Research, 12/10/09
Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09
Article Search
Sponsor